CDC/IDSA Lyme Criteria - IgM

Negative

A negative result for CDC/IDSA Lyme Criteria - IgM means that the test did not detect IgM antibodies specific to Borrelia burgdorferi, the bacterium responsible for Lyme disease, at levels high enough to meet the diagnostic criteria set by the Centers for Disease Control and Prevention (CDC) or the Infectious Diseases Society of America (IDSA). Here's what this typically means:

1. No Evidence of Recent Lyme Disease Infection

  • IgM antibodies are typically produced by the immune system within the first few weeks after infection. A negative IgM result generally indicates that there is no evidence of a recent infection with Borrelia burgdorferi, or the body has not yet started to produce IgM antibodies in response to the infection. This suggests that, at the time of testing, the individual may not be in the acute or early stage of Lyme disease.

2. Early Stage Infection Not Detected

  • In cases of early Lyme disease (usually within the first few weeks following a tick bite), IgM antibodies should be detectable in most individuals, as they are the first antibody type produced in response to the infection. If the IgM result is negative, it could mean:

    • The infection is in its very early stages, before the immune system has had time to produce detectable levels of IgM antibodies.

    • The test may have been performed too soon after the tick bite for IgM antibodies to appear.

In these cases, it is possible that the IgM test could become positive in subsequent weeks as the immune response develops.

3. Later Stage or Chronic Lyme Disease

  • For individuals with chronic Lyme disease or ongoing symptoms, a negative IgM result is common. In these cases, IgG antibodies are typically the predominant immune response, as IgM is more associated with the initial infection phase. Therefore, a negative IgM result in someone with chronic or longstanding Lyme disease symptoms may be expected, as the immune system has shifted from producing IgM to producing IgG antibodies.

4. False Negative or Cross-Reactivity

  • It is possible for the IgM test to return a false negative result in certain circumstances, such as:

    • The immune response to the infection is not strong enough to produce detectable levels of IgM antibodies.

    • The person has underlying immune system issues that affect the production of antibodies.

    • There may be cross-reactivity with other infections, leading to a false negative result.

5. Further Testing and Diagnosis

  • If Lyme disease is suspected despite a negative IgM result, additional testing may be recommended. This could include repeat testing after a few weeks, as the IgM antibodies may appear later in the infection. A Western blot test can also provide further clarification, and other tests such as PCR testing (for detecting the bacteria's genetic material) or clinical evaluation of symptoms may be necessary to confirm or rule out Lyme disease.

Conclusion

A negative CDC/IDSA Lyme Criteria - IgM result typically suggests that Lyme disease is not in the early stages or that the individual has not yet developed detectable IgM antibodies. However, if symptoms persist or Lyme disease is still suspected, it's important to consult a healthcare provider for further testing, additional evaluations, or possible repeat testing. Early diagnosis and treatment are essential to managing Lyme disease effectively, so any concerns should be addressed promptly with a healthcare professional.

CDC/IDSA Lyme Criteria - IgM
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond CDC/IDSA Lyme Criteria - IgM — 10,000+ markers explained
One CDC/IDSA Lyme Criteria - IgM result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro